ArticleAnnals of hematology2025

SARS-CoV-2 infection does not affect the outcome of patients with relapsed/refractory large B-cell lymphoma treated with CAR T-cell therapy.

Marianna Gentilini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.